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Although the type VI secretion system (T6SS) was discovered recently (1) , it is widespread in 11
Gram-negative bacteria. This presumably comes from the fitness advantage conferred by the 12 T6SS (i) in environmental niches against rival bacteria (inter-and intraspecies 13 competitiveness have been described) and (ii) in the eukaryotic host to commensal bacteria 14
(2). Moreover in addition to being an anti-eukaryotic weapon (2), the T6SS allows pathogens 15 to compete with microbiota during host colonization (3). This nanomachine functions as an 16 inverted contractile phage tail to deliver effectors into bacterial or eukaryotic cells (4). The 17 contraction of a sheath in the cytoplasm propels an inner tube made of Hcp proteins topped by 18 a puncturing device consisting of VgrG and PAAR proteins towards target cells. Effectors 19 associated with this expelled structure are thus translocated into host cells. The first described 20 T6SS effector was the evolved VgrG1 of Vibrio cholerae whose C-terminal extension cross-21 links actin (5). Since the discovery of VgrG1, several types of T6SS effectors have been 22 characterized. They are mainly dedicated to antibacterial activities (2), in some cases to the 23 battle with eukaryotic hosts (2), or even both (6, 7), which is very original and unusual for 24 bacterial toxins. Briefly three types of T6SS effectors have been characterized so far: C-25 terminal extensions of evolved VgrGs also referred to specialized effectors, specialized 26 PAAR proteins, and independent toxins also called cargo effectors that target various 27 components in bacteria (i.e. peptidoglycan, phospholipids, metabolism, nucleic acids) or are 28 anti-eukaryotic (i.e. bacteria internalization and autophagy). Hcp, VgrG and PAAR proteins 29 are also implicated in the recruiting and delivery of the cargo effectors (2). 30
Hcp proteins were therefore recognized as structural components of the T6SS machinery that 31 were also required for effector recruitment until the study of Ma and colleagues in this issue 32 given for this restriction since the C-terminal extensions of Hcp-ETs can be found in other 49 proteobacteria toxins excluding the hypothesis of a bacterial family specificity. As one might 50 expect, genes encoding immunity proteins were also found next to Hcp-ET coding genes. 51
Bacteria produce immunity proteins, which are also known as antitoxins, to prevent fratricide 52 attack or for self-protection in the case of a toxin that is active in the cytoplasm (2). 53
To gain further insight into the molecular mechanisms of some of these novel T6SS effectors, 54 the authors performed bacterial competition assays. They showed that the Hcp-ET1 of strain 55 STEC004 (Shiga toxin-producing E. coli) inhibits target cell growth through DNA 56 degradation and is neutralized by the immunity protein ETI1. They nicely demonstrated that 57 the Hcp conserved domain (DUF796) in Hcp-ET1 addresses the toxin to the T6SS2 58 machinery presumably through a heterohexamer formed with two other Hcps of the T6SS2, 59 namely Hcp2A and Hcp2B. Next, Hcp-ET2 of ETEC (enterotoxigenic E. coli) strain PE321 60 was shown to be evolutionary closed to the Tle1 family of antibacterial T6SS phospholipases 61 that harbor a GxSxG catalytic motif (12). They found that the Hcp-ET2 cognate immunity 62 protein, ETI2, directly interacts with Hcp-ET2 and that the DUF796 domain mediates the 63 targeting to the T6SS machinery. Similarly the authors studied the antibacterial activities of 64
Hcp-ET3 and of an orphan ET4 in the ETEC strain PE086. 65
Hcp is a key structural component of the T6SS that upon polymerization forms the long rigid 66 tube that is thrust towards the target cell upon sheath contraction. The data of Ma and 67 colleagues suggest that in the case of specialized Hcp-ETs, the DUF796 domain can interact with other Hcps to form heterohexameric rings that stack into a tube in the same way that important questions about the localization of the effector extensions within the Hcp tube. 71
Indeed, the effector domain position should still allow recognition between Hcp subunits and 72 further assembly. Likewise, the VgrG should accommodate the last Hcp hexamer of the tube 73 to form the sharp spike. And finally one can ask whether the extension is cleaved or not when 74 it reaches the target cell? 75 76
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